| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6823830 | Schizophrenia Research | 2015 | 7 Pages |
Abstract
: Clinicians should be cautious in switching patients with chronic schizophrenia who are stable on 2 antipsychotics to one antipsychotic. Given the challenges in discontinuing antipsychotic polypharmacy, adequate trials of evidence-based treatments such as clozapine and long-acting injectable antipsychotics should be undertaken in inadequately responsive schizophrenia patients before moving to antipsychotic polypharmacy.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Robert J. Constantine, Ross Andel, Marie McPherson, Rajiv Tandon,